SuperworthMAIA Biotechnology market cap MAIA
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $69.9M
- Highest close in our data
- $103.7M
- May 2024
MAIA Biotechnology is worth $69.9M at the close on Oct 23, 2026, at $1.15 a share.
That is up 48% over the last year.
Its highest close in our data was $103.7M in May 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $69.9M | $54.1M | $94.8M | +20% |
| 2025 | $58.1M | $33.8M | $60.7M | +10% |
| 2024 | $52.9M | $15.6M | $103.7M | +218% |
| 2023 | $16.6M | $12.8M | $53M | −57% |
| 2022 | $38.4M | $34.4M | $46.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest MAIA Biotechnology's size, closest first, today.
| Company | Market cap |
|---|---|
| MAIAMAIA Biotechnology | $69.9M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| Peer median | $477.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on MAIA Biotechnology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.